Tower Research Capital LLC (TRC) - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,275
-39.9%
3,591
-0.4%
0.00%
Q2 2023$2,123
+106050.0%
3,605
-1.0%
0.00%
Q1 2023$2
+100.0%
3,641
+63.0%
0.00%
Q4 2022$1
-99.9%
2,234
+156.5%
0.00%
Q3 2022$1,000
-83.3%
871
-84.0%
0.00%
Q2 2022$6,000
-40.0%
5,442
+62.1%
0.00%
Q1 2022$10,000
+900.0%
3,358
+1579.0%
0.00%
Q4 2021$1,0000.0%200
-14.2%
0.00%
Q2 2021$1,000
-75.0%
233
-62.7%
0.00%
Q1 2021$4,000
+300.0%
624
+670.4%
0.00%
Q4 2020$1,000810.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 388,632$2,048,0001.16%
Tri Locum Partners LP 522,943$2,756,0001.10%
Sio Capital Management, LLC 422,598$2,227,0000.71%
Affinity Asset Advisors, LLC 400,000$2,108,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 508,322$2,679,0000.22%
Ikarian Capital, LLC 99,422$524,0000.04%
PURA VIDA INVESTMENTS, LLC 105,141$554,0000.02%
Virtu Financial LLC 20,029$106,0000.01%
NEXT Financial Group, Inc 14,752$77,0000.01%
Schonfeld Strategic Advisors LLC 103,925$548,0000.01%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders